CN106232027A - 包括带倒钩的钉的钉仓 - Google Patents
包括带倒钩的钉的钉仓 Download PDFInfo
- Publication number
- CN106232027A CN106232027A CN201580021222.4A CN201580021222A CN106232027A CN 106232027 A CN106232027 A CN 106232027A CN 201580021222 A CN201580021222 A CN 201580021222A CN 106232027 A CN106232027 A CN 106232027A
- Authority
- CN
- China
- Prior art keywords
- tissue thickness
- nail
- compensating part
- cases
- lower limb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003141 lower extremity Anatomy 0.000 claims abstract description 200
- 238000010304 firing Methods 0.000 claims abstract description 140
- 239000012636 effector Substances 0.000 claims abstract description 109
- 208000026721 nail disease Diseases 0.000 claims 2
- 230000033001 locomotion Effects 0.000 abstract description 17
- 210000001519 tissue Anatomy 0.000 description 837
- 238000000034 method Methods 0.000 description 98
- 239000000463 material Substances 0.000 description 97
- 239000000203 mixture Substances 0.000 description 70
- 230000008569 process Effects 0.000 description 66
- 229920000642 polymer Polymers 0.000 description 61
- 238000009527 percussion Methods 0.000 description 43
- 229920000954 Polyglycolide Polymers 0.000 description 39
- 239000004633 polyglycolic acid Substances 0.000 description 39
- 230000008859 change Effects 0.000 description 34
- 230000006835 compression Effects 0.000 description 34
- 238000007906 compression Methods 0.000 description 34
- 238000005516 engineering process Methods 0.000 description 33
- 238000005520 cutting process Methods 0.000 description 23
- 239000006260 foam Substances 0.000 description 22
- 239000003607 modifier Substances 0.000 description 22
- 229920001610 polycaprolactone Polymers 0.000 description 22
- 239000004632 polycaprolactone Substances 0.000 description 22
- 230000009477 glass transition Effects 0.000 description 21
- 239000000243 solution Substances 0.000 description 19
- 238000003825 pressing Methods 0.000 description 17
- 238000007493 shaping process Methods 0.000 description 15
- 229920001971 elastomer Polymers 0.000 description 13
- 238000004108 freeze drying Methods 0.000 description 13
- 229920000747 poly(lactic acid) Polymers 0.000 description 12
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 11
- 229920001577 copolymer Polymers 0.000 description 11
- 239000000806 elastomer Substances 0.000 description 11
- 229920001432 poly(L-lactide) Polymers 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- JBFHTYHTHYHCDJ-UHFFFAOYSA-N gamma-caprolactone Chemical compound CCC1CCC(=O)O1 JBFHTYHTHYHCDJ-UHFFFAOYSA-N 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 9
- 239000004626 polylactic acid Substances 0.000 description 9
- 239000011521 glass Substances 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 230000007704 transition Effects 0.000 description 8
- 238000005452 bending Methods 0.000 description 7
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 7
- 239000000155 melt Substances 0.000 description 7
- 229920000117 poly(dioxanone) Polymers 0.000 description 7
- -1 poly-dioxane Ketone Chemical class 0.000 description 7
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 7
- VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000009940 knitting Methods 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 238000002161 passivation Methods 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 5
- SCRCZNMJAVGGEI-UHFFFAOYSA-N 1,4-dioxane-2,5-dione;oxepan-2-one Chemical compound O=C1COC(=O)CO1.O=C1CCCCCO1 SCRCZNMJAVGGEI-UHFFFAOYSA-N 0.000 description 5
- 239000013543 active substance Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000000017 hydrogel Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 238000005299 abrasion Methods 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000994 depressogenic effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000003116 impacting effect Effects 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 3
- 239000000560 biocompatible material Substances 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000007334 copolymerization reaction Methods 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000000622 polydioxanone Substances 0.000 description 3
- 239000004627 regenerated cellulose Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000009958 sewing Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229920005830 Polyurethane Foam Polymers 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000007731 hot pressing Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001308 poly(aminoacid) Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 239000011496 polyurethane foam Substances 0.000 description 2
- 229920002620 polyvinyl fluoride Polymers 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000003356 suture material Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000009941 weaving Methods 0.000 description 2
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 1
- MFRCZYUUKMFJQJ-UHFFFAOYSA-N 1,4-dioxane-2,5-dione;1,3-dioxan-2-one Chemical compound O=C1OCCCO1.O=C1COC(=O)CO1 MFRCZYUUKMFJQJ-UHFFFAOYSA-N 0.000 description 1
- 229930195573 Amycin Natural products 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 208000013641 Cerebrofacial arteriovenous metameric syndrome Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920004937 Dexon® Polymers 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- IWDQPCIQCXRBQP-UHFFFAOYSA-M Fenaminosulf Chemical compound [Na+].CN(C)C1=CC=C(N=NS([O-])(=O)=O)C=C1 IWDQPCIQCXRBQP-UHFFFAOYSA-M 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920000305 Nylon 6,10 Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 239000004775 Tyvek Substances 0.000 description 1
- 229920000690 Tyvek Polymers 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- ZSTLPJLUQNQBDQ-UHFFFAOYSA-N azanylidyne(dihydroxy)-$l^{5}-phosphane Chemical compound OP(O)#N ZSTLPJLUQNQBDQ-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000002599 biostatic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229940097572 chloromycetin Drugs 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000019628 coolness Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 150000003997 cyclic ketones Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- FYIBGDKNYYMMAG-UHFFFAOYSA-N ethane-1,2-diol;terephthalic acid Chemical compound OCCO.OC(=O)C1=CC=C(C(O)=O)C=C1 FYIBGDKNYYMMAG-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 102000005525 fibrillarin Human genes 0.000 description 1
- 108020002231 fibrillarin Proteins 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229920001821 foam rubber Polymers 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-N n-Decanedioic acid Natural products OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-M naproxen(1-) Chemical compound C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-M 0.000 description 1
- 229910001120 nichrome Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical group O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 description 1
- 229950000845 politef Drugs 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001230 polyarylate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 1
- 229960000894 sulindac Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 238000004017 vitrification Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111039864.0A CN113693658A (zh) | 2014-02-24 | 2015-01-21 | 包括带倒钩的钉的端部执行器 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/187,400 | 2014-02-24 | ||
US14/187,400 US20140166726A1 (en) | 2014-02-24 | 2014-02-24 | Staple cartridge including a barbed staple |
PCT/US2015/012156 WO2015126555A1 (en) | 2014-02-24 | 2015-01-21 | Staple cartridge including a barbed staple |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111039864.0A Division CN113693658A (zh) | 2014-02-24 | 2015-01-21 | 包括带倒钩的钉的端部执行器 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106232027A true CN106232027A (zh) | 2016-12-14 |
Family
ID=56616516
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111039864.0A Pending CN113693658A (zh) | 2014-02-24 | 2015-01-21 | 包括带倒钩的钉的端部执行器 |
CN201580021222.4A Pending CN106232027A (zh) | 2014-02-24 | 2015-01-21 | 包括带倒钩的钉的钉仓 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111039864.0A Pending CN113693658A (zh) | 2014-02-24 | 2015-01-21 | 包括带倒钩的钉的端部执行器 |
Country Status (7)
Country | Link |
---|---|
JP (1) | JP6545719B2 (no) |
CN (2) | CN113693658A (no) |
AU (1) | AU2015219502B2 (no) |
BR (1) | BR112016018601B1 (no) |
CA (1) | CA2940136C (no) |
MX (1) | MX2016010955A (no) |
RU (1) | RU2676520C2 (no) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107582122A (zh) * | 2016-07-08 | 2018-01-16 | 美迪涂丽普有限公司 | 外科线性缝合器的端部执行器 |
CN110799109A (zh) * | 2017-06-27 | 2020-02-14 | 爱惜康有限责任公司 | 外科砧座制造方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1222981A (en) * | 1968-02-17 | 1971-02-17 | Gkn South Wales Ltd | Improvements in or relating to staples |
US3757629A (en) * | 1971-05-10 | 1973-09-11 | R Schneider | Resilient plastic staple |
US4454875A (en) * | 1982-04-15 | 1984-06-19 | Techmedica, Inc. | Osteal medical staple |
US20020019636A1 (en) * | 1999-04-23 | 2002-02-14 | James Ogilvie | Shape memory alloy sample |
US20100256675A1 (en) * | 2009-04-03 | 2010-10-07 | Romans Matthew L | Absorbable surgical staple |
US20130153627A1 (en) * | 2011-12-19 | 2013-06-20 | Charles L. Euteneuer | Fasteners and fastener delivery devices for affixing sheet-like materials to bone or tissue |
US20130214030A1 (en) * | 2010-09-30 | 2013-08-22 | Ethicon Endo-Surgery, Inc. | Actuator for releasing a tissue thickness compensator from a fastener cartridge |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0389102B1 (en) * | 1989-02-22 | 1995-05-10 | United States Surgical Corporation | Skin fastener |
RU2161450C1 (ru) * | 1999-07-22 | 2001-01-10 | Каншин Николай Николаевич | Хирургический сшиватель |
CN2548577Y (zh) * | 2002-05-15 | 2003-05-07 | 张德胜 | 镍钛弧型加压骑缝钉 |
RU61122U1 (ru) * | 2006-07-14 | 2007-02-27 | Нина Васильевна Гайгерова | Хирургический сшиватель |
US7794475B2 (en) * | 2006-09-29 | 2010-09-14 | Ethicon Endo-Surgery, Inc. | Surgical staples having compressible or crushable members for securing tissue therein and stapling instruments for deploying the same |
US9301752B2 (en) * | 2010-09-30 | 2016-04-05 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator comprising a plurality of capsules |
US8821543B2 (en) * | 2010-12-23 | 2014-09-02 | Depuy Mitek, Llc | Adjustable anchor systems and methods |
WO2013009993A1 (en) * | 2011-07-12 | 2013-01-17 | Bengtson Bradley P | Surgical fixation devices, systems, and methods |
-
2015
- 2015-01-21 BR BR112016018601-0A patent/BR112016018601B1/pt active IP Right Grant
- 2015-01-21 RU RU2016137803A patent/RU2676520C2/ru not_active IP Right Cessation
- 2015-01-21 AU AU2015219502A patent/AU2015219502B2/en not_active Ceased
- 2015-01-21 MX MX2016010955A patent/MX2016010955A/es active IP Right Grant
- 2015-01-21 CN CN202111039864.0A patent/CN113693658A/zh active Pending
- 2015-01-21 CA CA2940136A patent/CA2940136C/en active Active
- 2015-01-21 CN CN201580021222.4A patent/CN106232027A/zh active Pending
- 2015-01-21 JP JP2016570765A patent/JP6545719B2/ja not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1222981A (en) * | 1968-02-17 | 1971-02-17 | Gkn South Wales Ltd | Improvements in or relating to staples |
US3757629A (en) * | 1971-05-10 | 1973-09-11 | R Schneider | Resilient plastic staple |
US4454875A (en) * | 1982-04-15 | 1984-06-19 | Techmedica, Inc. | Osteal medical staple |
US20020019636A1 (en) * | 1999-04-23 | 2002-02-14 | James Ogilvie | Shape memory alloy sample |
US20100256675A1 (en) * | 2009-04-03 | 2010-10-07 | Romans Matthew L | Absorbable surgical staple |
US20130214030A1 (en) * | 2010-09-30 | 2013-08-22 | Ethicon Endo-Surgery, Inc. | Actuator for releasing a tissue thickness compensator from a fastener cartridge |
US20130153627A1 (en) * | 2011-12-19 | 2013-06-20 | Charles L. Euteneuer | Fasteners and fastener delivery devices for affixing sheet-like materials to bone or tissue |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107582122A (zh) * | 2016-07-08 | 2018-01-16 | 美迪涂丽普有限公司 | 外科线性缝合器的端部执行器 |
CN107582122B (zh) * | 2016-07-08 | 2020-05-22 | 美迪涂丽普有限公司 | 外科线性缝合器的端部执行器 |
CN110799109A (zh) * | 2017-06-27 | 2020-02-14 | 爱惜康有限责任公司 | 外科砧座制造方法 |
CN110799109B (zh) * | 2017-06-27 | 2023-06-06 | 爱惜康有限责任公司 | 外科砧座制造方法 |
Also Published As
Publication number | Publication date |
---|---|
RU2016137803A3 (no) | 2018-08-21 |
CA2940136C (en) | 2022-08-30 |
CA2940136A1 (en) | 2015-08-27 |
AU2015219502A1 (en) | 2016-08-18 |
BR112016018601B1 (pt) | 2022-06-21 |
JP6545719B2 (ja) | 2019-07-17 |
MX2016010955A (es) | 2017-04-27 |
BR112016018601A2 (no) | 2017-08-08 |
CN113693658A (zh) | 2021-11-26 |
AU2015219502B2 (en) | 2019-03-14 |
RU2016137803A (ru) | 2018-03-29 |
RU2676520C2 (ru) | 2018-12-29 |
JP2017506142A (ja) | 2017-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106232032B (zh) | 包括压制区域的可植入层 | |
CN106232029B (zh) | 包括击发构件锁定件的紧固系统 | |
EP2910197B1 (en) | Methods for altering one or more properties of implantable layers for use with fastening instruments | |
CN106232031A (zh) | 包括带倒钩的钉的钉仓 | |
CN106232027A (zh) | 包括带倒钩的钉的钉仓 | |
CN106232028B (zh) | 可植入层组件 | |
CN106413577B (zh) | 可植入层和用于改变与外科紧固器械一起使用的可植入层的方法 | |
CN106232030B (zh) | 可植入层和用于修改与外科紧固器械一起使用的可植入层的形状的方法 | |
CN106456162B (zh) | 可植入层以及用于改变与紧固器械一起使用的可植入层的一个或多个特性的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161214 |
|
RJ01 | Rejection of invention patent application after publication |